Themis Medicare Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Themis Medicare Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 2 of the last 3 years; profit grew in 0 of 3. Less steady than 94% of Healthcare companies in India.
- Cash Locked Ratio: For every ₹100 of sales, ₹53 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹42 tied up three years earlier. More money tied up than 93% of Healthcare companies in India.
- Tangible Net Worth Ratio: Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 91% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹72Over the last 3 years, every ₹100 of reported profit came with ₹72 of operating cash.
Lower than 77% of Healthcare companies in India.
Self-Funding Ratio
1.4×Over the last 3 years its own operating cash covered its investment spending (capex) 1.4 times.
Higher than 52% of Healthcare companies in India.
Cash Locked Ratio
₹53For every ₹100 of sales, ₹53 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹42 tied up three years earlier.
More money tied up than 93% of Healthcare companies in India.
Growth quality
Steadiness Ratio
2/3 · 0/3Sales grew in 2 of the last 3 years; profit grew in 0 of 3.
Less steady than 94% of Healthcare companies in India.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by -1% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
-1% / +16%In 3 years sales changed by -1% while total assets changed by +16%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-0.0×Operating cash was negative last year, while some debt falls due within a year.
Lower than 90% of Healthcare companies in India.
Cash Cushion Ratio
−11%Debt, after subtracting cash, equals 11% of its market value (net debt).
Lower than 80% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 91% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 91% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Themis Medicare Limited owes ₹0.33 for every ₹1 it owns. Net profit fell 96% in the year to Mar 2026, and shrank 73% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
21.8Investors pay ₹21.8 for every ₹1 of Themis Medicare Limited's yearly profit, lower than 80% of Healthcare companies in India.
P/B ratio
2.19The share price is 2.19 times Themis Medicare Limited's book value per share, lower than 86% of Healthcare companies in India.
Market cap
₹871 CrThe total market value of all of Themis Medicare Limited's shares at today's price (share price × number of shares), smaller than 82% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹399 CrWhat Themis Medicare Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹43.28Net worth divided by the number of shares. The share price of ₹94.59 is 2.2 times this, which is the P/B above.
Return on equity (ROE)
10.1%Themis Medicare Limited earned 10.1% on its shareholders' money over the last year, lower than 67% of Healthcare companies in India.
Owes vs Owns
0.33×Themis Medicare Limited owes ₹0.33 for every ₹1 it owns (low), lower than 60% of Healthcare companies in India.
Dividend yield
0.47%Themis Medicare Limited pays 0.47% of its share price as dividends a year, higher than 60% of dividend-paying Healthcare companies in India.
Revenue growth
-15%Revenue fell 15% in the year to Mar 2026, and shrank 0% a year on average over 3 years.
Profit growth
-96%Net profit fell 96% in the year to Mar 2026, and shrank 73% a year on average over 3 years.
Profit margin
0.3%Themis Medicare Limited keeps ₹0 of every ₹100 of revenue as net profit.
Cash quality
-2.9×Cash from Themis Medicare Limited's business was -2.9× its reported profit in the year to Mar 2026 — the business used cash even though it reported a profit.
Interest cover
Not coveredThemis Medicare Limited's operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net debtThemis Medicare Limited had ₹96 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Themis Medicare Limited's P/E ratio?
Investors pay ₹21.8 for every ₹1 of Themis Medicare Limited's yearly profit, lower than 80% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Themis Medicare Limited: ₹871 Cr ÷ ₹399 Cr (31 Mar 2026) = 2.2.
What is Themis Medicare Limited's return on equity?
Themis Medicare Limited earned 10.1% on its shareholders' money over the last year, lower than 67% of Healthcare companies in India.
How much does Themis Medicare Limited owe compared with what it owns?
Themis Medicare Limited owes ₹0.33 for every ₹1 it owns (low), lower than 60% of Healthcare companies in India.
Does Themis Medicare Limited pay a dividend?
Yes. Themis Medicare Limited pays 0.47% of its share price as dividends a year, higher than 60% of dividend-paying Healthcare companies in India.
Is Themis Medicare Limited's revenue growing?
Revenue fell 15% in the year to Mar 2026, and shrank 0% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.